These observations are in line with findings of a recent report where Fpr2-deficient mice were protected against streptozotocin-induced cognitive deficits [51], which has been suggested to recapitulate distinct aspects of the AD pathology. The gene discussed is FPR2; the disease is Alzheimer disease.